重磅日程出炉，30位国际大咖共促生物医药产业发展—2019无锡国际生物医药论坛暨第九届CellDeath&Disease国际研讨会-新药研发
本次学术大会以无锡华泰创新药研究院为国际科技合作与学术交流平台，邀请生物医药领域具国际影响力的世界顶尖科学家、领域发展前沿的先驱者，围绕肿瘤细胞免疫、小分子靶向药物、单克隆抗体药物、细胞药物与细胞治疗研究与发展、理论与实践、技术与策略等进行大会学术交流，以助力我国生物医药研发创新与产业发展。这次学术大会是国际生物医药领域的一场科学盛宴，是面向高校、科研院所、医疗机构和生物医药企业创新发展需求，极具启发、引导作用的一次头脑风暴。本次大会还特别邀请了SpringerNature旗下的CellDeath&Disease杂志社主编赴会与参会人员交流，并作“HowtoGetPublished”专题报告，以满足科研人员论文发表的需要。
议题一：免疫调节与炎症性疾病
议题二：DNA损伤与癌症和衰老
议题三：癌症免疫治疗
议题四：间充质干细胞及其应用
议题五：细胞死亡与自噬
议题七：知识产权保护与申请
议题八：如何发表高水平研究论文
新日程：
|
Programme of The Wuxi International Bioforum 2019 and |
|||
|
November 4-6, 2019 |
|||
|
Sunday 3rd November |
|||
|
10:00 – 19:00 |
Registration |
||
|
Monday 4th November |
|||
|
10:00 – 12:50 |
Registration |
||
|
12:50 – 13:00 |
Welcome Address by Gerry Melino |
||
|
Session I: Immunoregulation and Inflammatory Diseases 13:00-14:30 |
|||
|
Chair: Tak Wah Mak |
|||
|
13:00 – 13:30 |
TBA |
Michel Sadelain |
Memorial Sloan Kettering, USA |
|
13:30 – 14:00 |
Targeting RAS in Cancer |
Ruibao Ren |
Shanghai Jiao-Tong University, China |
|
14:00 – 14:30 |
Coffee Break |
||
|
Session II: DNA Damage Response in Cancer and Aging 14:30-17:00 |
|||
|
Chair: Francesco Dazzi |
|||
|
14:30 – 15:00 |
ZNF281 Contributes to the DNA Damage Response and is A Prognostic Maker for Neuroblastoma |
Gerry Melino |
University of Rome-Tor Vergata, Italy |
|
15:00 – 15:30 |
Inherited Cancers, Normal and Accelerated Aging: the Role of POLD1 Gene in Nuclear Shape and DNA Damage Repair |
Giuseppe Novelli |
University of Rome-Tor Vergata, Italy |
|
15:30 – 16:00 |
TBA |
Eike-Christin von Leitner or Susanne Arbogast, Indivumed |
Germany |
|
16:00 – 16:30 |
Aging-induced IL27Rα Signaling Impairs Hematopoietic Stem Cells |
Jianwei Wang |
Tsinghua University, China |
|
16:30 – 17:00 |
TBA |
Changshun Shao |
Soochow University, China |
|
17:30 |
Welcome Reception in Wuxi (Banquet) |
||
|
Tuesday 5th November |
|||
|
08:00 – 09:00 |
Opening Ceremony |
||
|
Session III: Neuro Immunology 9:00-10:00 |
|||
|
Chair: Chen Dong |
|||
|
09:00 – 09:30 |
TBA |
Tak Wah Mak |
University of Toronto, Canada |
|
09:30 – 10:00 |
The Diverse Roles of Matrix Metalloproteinase (MMP)-2 and MMP-9 in the Induction and Progression of Neuroinflammation |
Lydia Sorokin |
University of Münster, Germany |
|
10:00 – 10:30 |
Coffee Break |
||
|
Session IV: Novel Approaches to Critical Diseases 10:30-12:30 |
|||
|
Chair: Yong-Guang Yang |
|||
|
10:30 – 11:00 |
Novel Affinity-matured Peptide-exchangeable Peptide/HLA Multimers Enable Robust and Rigorous Identification of Antigen-Specific T cells |
Naoto Hirano |
University of Toronto, Canada |
|
11:00 – 11:30 |
Emerging Techniques to Identify Antigenic Targets for the Treatment of Solid Tumors |
Hans-Peter Gerber |
3T Biosciences, USA |
|
11:30 – 12:00 |
Role of CD47-SIRPα Signaling in Transplantation and Cancer Immunology |
Yong-Guang Yang |
Jilin University, China |
|
12:00 – 12:30 |
TBA |
Chen Dong |
Tsinghua University, China |
|
12:30 |
Lunch |
||
|
Session V: Novel Models for Future Theraputics 14:00-15:30 |
|||
|
Chair: Willem Fibbe |
|||
|
14:00 – 14:30 |
Fallen Angels: Mechanisms of T Cell Lymphoma |
Jürgen Ruland |
Techincal University Munich, Germany |
|
14:30 – 15:00 |
CRISPR Gene Regulation and Biomedical Application |
Min Wu |
University of North Dakota, USA |
|
15:00 – 15:30 |
The Robust Oncolytic Adenoviral Therapeutics Against the Majority of Type of Cancer, Targeted by A Smart Synthetic Tumor Specific Promoter |
Jingde Zhu |
The First Affiliated Hospital of USTC, China |
|
15:30-16:00 |
Coffee Break |
||
|
Session VI: Cell Death and Autophagy 16:00-17:00 |
|||
|
Chair: Yong-Jun Liu |
|||
|
16:00 – 16:30 |
Transglutaminase Type 2 in the Regulation of Proteostasis |
Mauro Piacentini |
University of Rome-Tor Vergata, Italy |
|
16:30 – 17:00 |
The p63 C-terminus is Essential for Ovary Development |
Eleonora Candi |
University of Rome-Tor Vergata, Italy |
|
17:30 |
Dinner |
||
|
Wendesday 6 th November |
|||
|
Session VII: How to Get Publish in NPG and Apply Patent 7:00-9:00 |
|||
|
Chair: Yufang Shi |
|||
|
07:00 – 07:30 |
How to Write a Scientific Paper |
Gerry Melino |
University of Rome-Tor Vergata, Italy |
|
07:30 – 08:00 |
How to Get Published |
Rebecca Shreeve |
Springer Nature, UK |
|
08:00 – 08:20 |
TBA |
Xun Xu |
Xu & Partents LLC, China |
|
08:20 – 08:40 |
TBA |
Zhixin He |
Zhixin & Partners Law Firm Limited, China |
|
08:40 – 09:00 |
Patent Protection for Cell and Immunotherapy |
Michael X. Ye |
MORRIS, MANNING & MARTIN, LLP, USA |
|
Session VIII: New Drug Discovery 9:00-10:30 |
|||
|
Chair: Giuseppe Novelli |
|||
|
09:00 – 09:30 |
Reimagining Druggability Using Chemoproteomic Platforms |
Daniel Nomura |
University of California, USA |
|
09:30 – 10:00 |
Drug Discovery from Natural Products Library and Traditional Chinese Medicine |
Qinshi Zhao |
CAS, China |
|
10:00 – 10:30 |
Translating Human Immunobiology to Medicine |
Yong-Jun Liu |
Sanofi, UK |
|
10:30 – 11:00 |
Coffee Break |
||
|
Session IX: Mesenchymal Stem Cells and Their Applications 11:00-13:00 |
|||
|
Chair: Lydia Sorokin |
|||
|
11:00 – 11:30 |
TBA |
Yufang Shi |
Soochow University, China |
|
11:30 – 12:00 |
Mesenchymal Stromal Cells, Death and Disease |
Francesco Dazzi |
King's College London, UK |
|
12:00 – 12:30 |
A Mechanistic Approach to Mesenchymal Stromal Cell Therapy |
Willem Fibbe |
Leiden University, Netherland |
|
12:30 – 13:00 |
Switching Macrophage: A Novel Therapeutic Strategy for Autoimmune Diseases |
Ying Wang |
CAS, China |
注册报名：
|
票价类型 |
学生票 |
科研院所票 |
企业票 |
|
单价 |
500元/人 |
1000元/人 |
2000元/人 |
|
注意事项 |
包含会议资料、午餐、茶歇等，不含住宿及晚餐。 |
||
大会联系人：
尚倩雯
0510-83592811
无锡华泰创新药技术研究院有限公司
无锡市惠山区惠山大道1699号生命科技产业园C区6号楼
冯超
0512-65883432
苏州大学转化医学研究院
江苏省苏州市工业园区仁爱路199号
赞助和大会咨询：
汤海荣
E-mail：hairong.tang@bioon.com
Mt：13524820860
参会和媒体合作：
何春幸
E-mail：chunxing.he@medsci.cn
Mt：17321098232
